• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.13% Nasdaq Up0.14%

    More On PGL.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    TBG Diagnostics Limited (PGL.AX)

    -ASX
    0.23 0.00(0.00%) Dec 3
    ProfileGet Profile for:
    TBG Diagnostics Limited
    101 Collins Street
    Level 18
    Melbourne, VIC 3000
    Australia - Map
    Phone: 61 7 3273 9133
    Fax: 61 7 3375 1168
    Website: http://www.progen-pharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:N/A

    Business Summary 

    TBG Diagnostics Limited, a biotechnology company, focuses on the development, manufacture, and marketing of nucleic acid test kits. It also provides associated services. In addition, the company is involved in the development of a low resolution human leukocyte antigen (HLA) sequencespecific primer (SSP) typing kit prototype products; a high resolution HLA typing product based on sequence based typing (SBT); and oncology products for the testing of targeted cancer therapy for non-small cell lung cancer, colorectal, and melanoma, as well as NAT blood screening business. Further, it manufactures virology products; and sells automated pipetting systems, NAT extracting systems, and automated blood screening systems consumables. The company was formerly known as Progen Pharmaceuticals Limited and changed its name to TBG Diagnostics Limited in December 2015. The company is based in Melbourne, Australia.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on TBG Diagnostics Limited

    Key Executives 
     PayExercised
    Mr. Indrajit Solomon Arulampalam ,
    Exec. Chairman
    N/AN/A
    Ms. Generosa Hipona ,
    Acting Gen. Mang. of Fin.
    N/AN/A
    Ms. Fleur Lankesheer BSc, LLB,
    Director of Legal & Bus. Devel.
    N/AN/A
    Dr. Edward Hammond ,
    Head of Biology
    N/AN/A
    Dr. Paul Handley ,
    Head of Chemistry
    N/AN/A
    Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in AUD.